October 23, 2012
Nippon Chemiphar announced on October 19 that its investigational neuropathic pain treatment targeting P2X4 receptor, which is being jointly researched with the Kyushu University Graduate School of Pharmaceutical Sciences (Prof. Kazuhide Inoue), will be funded by the Japan Science and...read more